These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 35727174)
1. Spontaneous Regression of Blastic Plasmacytoid Dendritic Cell Neoplasm Following Sepsis by Serratia marcescens: A Case Report and Literature Review. Suzuki A; Abe S; Koyama K; Suzuki S; Nagao M; Kobayashi M; Nomura J; Tsutsumi T; Takeda T; Oka Y; Shirota Y; Takasawa N; Kodera T; Okitsu Y; Takahashi S; Ichinohasama R; Kameoka J Intern Med; 2021; 60(6):927-933. PubMed ID: 33716255 [TBL] [Abstract][Full Text] [Related]
2. [Blastic plasmacytoid dendritic cell tumor treated with DVT regimen: a case report and literature review]. Shi J; Xu N; Niu Y; Jia SX; Yang CM; Fang MY Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):86-89. PubMed ID: 38527844 [TBL] [Abstract][Full Text] [Related]
4. A non-resolving bruise and the 'pearl necklace'-Blastic plasmacytoid dendritic cell neoplasm. Lam WK; Kong SY Br J Haematol; 2024 Apr; 204(4):1131. PubMed ID: 38323480 [No Abstract] [Full Text] [Related]
5. Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis. Yamada T; Hiramoto N; Mori T; Yamashita D; Tai Y; Yamamoto R; Nishikubo M; Maruoka H; Sakamoto K; Takeuchi K; Nannya Y; Ogawa S; Ishikawa T Blood Cancer J; 2023 Aug; 13(1):119. PubMed ID: 37558659 [No Abstract] [Full Text] [Related]
6. Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Abdallah M; McCullough K; Ilyas R; Begna KH; Al-Kali A; Litzow MR; Hogan WJ; Mangaonkar A; Alkhateeb H; Shah MV; Elliott MA; Foran JM; Badar T; Palmer JM; Yi CA; Sproat L; Pardanani A; Patnaik MM; Olteanu H; Ketterling RP; Tefferi A; Gangat N Blood Cancer J; 2023 Mar; 13(1):35. PubMed ID: 36907917 [No Abstract] [Full Text] [Related]
7. Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm: a 2-speed cure in the United States and European Union. Valentini CG; Pagano L Blood Adv; 2023 Nov; 7(22):7084-7086. PubMed ID: 37847911 [No Abstract] [Full Text] [Related]
8. More on Blastic Plasmacytoid Dendritic-Cell Neoplasms. Agha ME; Monaghan SA; Swerdlow SH N Engl J Med; 2019 Feb; 380(7):696-697. PubMed ID: 30763185 [No Abstract] [Full Text] [Related]
9. More on Blastic Plasmacytoid Dendritic-Cell Neoplasms. Micol JB; Pilorge S; Ghez D N Engl J Med; 2019 Feb; 380(7):696. PubMed ID: 30785715 [No Abstract] [Full Text] [Related]
10. Ocular and central nervous system relapse of Blastic Plasmacytoid Dendritic Cell Neoplasm. Gonzaga Y; Vieira C; Mattosinho C Br J Haematol; 2023 Nov; 203(3):345-346. PubMed ID: 37670205 [No Abstract] [Full Text] [Related]
11. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need. Pemmaraju N; Kantarjian H; Sweet K; Wang E; Senapati J; Wilson NR; Konopleva M; Frankel AE; Gupta V; Mesa R; Ulrickson M; Gorak E; Bhatia S; Budak-Alpdogan T; Mason J; Garcia-Romero MT; Lopez-Santiago N; Cesarman-Maus G; Vachhani P; Lee S; Bhatt VR; Blum W; Walter RB; Bixby D; Gojo I; Duvic M; Rampal RK; de Lima M; Foran J; Fathi AT; Hall AC; Jacoby MA; Lancet J; Mannis G; Stein AS; Mims A; Rizzieri D; Olin R; Perl A; Schiller G; Shami P; Stone RM; Strickland S; Wieduwilt MJ; Daver N; Ravandi F; Vasu S; Guzman M; Roboz GJ; Khoury J; Qazilbash M; Aung PP; Cuglievan B; Madanat Y; Kharfan-Dabaja MA; Pawlowska A; Taylor J; Tallman M; Dhakal P; Lane AA Blood; 2023 Feb; 141(6):567-578. PubMed ID: 36399715 [TBL] [Abstract][Full Text] [Related]
12. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies. Mehra S; Taylor J Cells; 2024 Jan; 13(3):. PubMed ID: 38334635 [TBL] [Abstract][Full Text] [Related]
13. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Cuglievan B; Connors J; He J; Khazal S; Yedururi S; Dai J; Garces S; Quesada AE; Roth M; Garcia M; McCall D; Gibson A; Ragoonanan D; Petropoulos D; Tewari P; Nunez C; Mahadeo KM; Tasian SK; Lamble AJ; Pawlowska A; Hammond D; Maiti A; Haddad FG; Senapati J; Daver N; Gangat N; Konopleva M; Meshinchi S; Pemmaraju N Leukemia; 2023 Sep; 37(9):1767-1778. PubMed ID: 37452102 [TBL] [Abstract][Full Text] [Related]
14. Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm. Luskin MR; Lane AA Haematologica; 2024 Jan; 109(1):44-52. PubMed ID: 36951152 [TBL] [Abstract][Full Text] [Related]
15. Blastic Plasmacytoid Dendritic Cell Neoplasm With Central Nervous System Involvement: A Case Report. Molina Castro D; Perilla Suárez O; Cuervo-Sierra J; Moreno A Cureus; 2022 Apr; 14(4):e23888. PubMed ID: 35530883 [TBL] [Abstract][Full Text] [Related]
16. Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Davis JA; Rizzieri DA; Lane AA; Taylor J; Faisal MS; Vasu S; Soong D; Li H; Herbst A; Greenwell IB Leuk Lymphoma; 2022 Nov; 63(11):2757-2759. PubMed ID: 35727174 [No Abstract] [Full Text] [Related]
17. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy. Martín-Martín L; Almeida J; Pomares H; González-Barca E; Bravo P; Giménez T; Heras C; Queizán JA; Pérez-Ceballos E; Martínez V; Alonso N; Calvo C; Álvarez R; Caballero MD; Orfao A Oncotarget; 2016 Mar; 7(9):10174-81. PubMed ID: 26840087 [TBL] [Abstract][Full Text] [Related]